Efficacy of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year findings from DIVA.

被引：0
|
作者：
Bolognese, M
Reid, DM
Langdahl, B
Hughes, C
Ward, P
Masanauskaite, D
Olszynski, WP
机构：
[1] Bethesda Hlth Res, Bethesda, MD USA
[2] Univ Aberdeen, Aberdeen, Scotland
[3] Arhus Amtssygehus, Aarhus, Denmark
[4] F Hoffmann La Roche Ltd, Basel, Switzerland
[5] Midtown Med Ctr, Saskatoon, SK, Canada
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [21] Rationale for intermittent intravenous Ibandronate injections in postmenopausal osteoporosis.
    Miller, PD
    Recker, RR
    Adami, S
    Bonvoisin, B
    Schimmer, RC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S263 - S263
  • [22] Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis
    Thiebaud, D
    Burckhardt, P
    Kriegbaum, H
    Huss, H
    Juttmann, JR
    Schoter, KH
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (04): : 298 - 307
  • [23] Four years intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis
    Lamy, O
    Sandini, L
    Burnand, J
    Krieg, MA
    Burckhardt, P
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S188 - S188
  • [24] Intravenous ibandronate injections in postmenopausal women with osteoporosis - One-year results from the dosing intravenous administration study
    Delmas, Pierre D.
    Adami, Silvano
    Strugala, Cezary
    Stakkestad, Jacob A.
    Reginster, Jean-Yves
    Felsenberg, Dieter
    Christiansen, Claus
    Civitelli, Roberto
    Drezner, Marc K.
    Recker, Robert R.
    Bolognese, Michael
    Hughes, Claire
    Masanauskaite, Daiva
    Ward, Penelope
    Sambrook, Philip
    Reid, David M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (06): : 1838 - 1846
  • [25] Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
    Recker, Robert R.
    Ste-Marie, Louis-George
    Langdahl, Bente
    Czerwinski, Edward
    Bonvoisin, Bernard
    Masanauskaite, Daiva
    Rowell, Lucy
    Felsenberg, Dieter
    BONE, 2010, 46 (03) : 660 - 665
  • [26] Tri-monthly intravenous injections of ibandronate for treatment of postmenopausal osteoporosis
    Brenner, K
    Loho, N
    Mirzai, S
    Keck, AV
    Hoyle, N
    Felsenberg, D
    Pecherstorfer, M
    BONE, 2002, 30 (03) : 47S - 47S
  • [27] Novel ibandronate regimens in postmenopausal osteoporosis: Design of the dosing intravenous administration (DIVA) study
    Sambrook, P
    Reginster, JY
    Recker, RR
    Seeman, E
    Nuti, R
    Kelly, S
    Gilbride, J
    Bonvoisin, B
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S118 - S118
  • [28] Quarterly intravenous ibandronate injections provide continuing benefits in women with postmenopausal osteoporosis: DIVA study long-term extension
    Recknor, C.
    Lillestol, M.
    Grant, R.
    Neate, C.
    Recker, R. R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S453 - S453
  • [29] Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Miller, PD
    McClung, MR
    Macovei, LV
    Stakkestad, JA
    Luckey, M
    Bonvoisin, B
    Reginster, JY
    Recker, RR
    Hughes, C
    Lewiecki, EM
    Felsenberg, D
    Delmas, PD
    Kendler, DL
    Bolognese, MA
    Mairon, N
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) : 1315 - 1322
  • [30] Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Recker, RR
    Silverman, SL
    Kendler, DL
    Dumont, E
    Hughes, BBC
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S293 - S294
12345